A cross-national comparison of nonmedical and medical use of psychedelic drugs in the international cannabis policy study.
International Journal of Drug Policy August 1, 2026 Myfanwy Graham, Yimin Ge, Rosalie Liccardo Pacula et al. 1 citation
We know little about the extent psychedelic substances are consumed therapeutically and/or discussed with medical professionals despite renewed global interest in these substances. We examined self-reported responses from the 2023 International Cannabis Policy Study (ICPS) in repeated cross-sectional surveys in Canada, the United States, Australia, and New Zealand. The survey included questions...
DOI: 10.1016/j.drugpo.2026.105348 (opens in new tab)
Full text (opens in new tab)
Adverse events
Drug policy
Nonmedical use
Psychedelics